Show simple item record

Evaluación del tratamiento de Linfoma de Hodgkin con esquema ABVD en Chile

TREATMENT OF HODGKIN LYMPHOMA. ANALYSIS OF 915 PATIENTS

dc.contributores-ES
dc.contributoren-US
dc.creatorCabrera C, María Elena; Hospital del Salvador
dc.creatorPuga L, Barbara; Hospital del Salvador
dc.creatorTorres, Vivianne; Hospital Regional Valdivia
dc.creatorSalinas, Mauricio; Hospital del Torax
dc.date2019-04-16
dc.date.accessioned2019-11-11T18:27:36Z
dc.date.available2019-11-11T18:27:36Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/7205
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111209
dc.descriptionBackground: Hodgkin lymphoma has a high rate of curability, even in advanced stages. Aim: To assess the results of Hodgkin lymphoma treatment using the ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy regimen. Material and methods: Analysis of a database held by the Chilean Ministry of Health, including all patients treated at accredited cancer treatment centers. Results: Data for915 patients, median age 35 years (range 15-86 years) and followed for a median of 97 months (range 1-347 months) were analyzed. Forty-one percent had localized disease. Overall survival at five years for localized and advanced stages was 92% and 74%, respectively. The figures for progression free survival were 87% and 64%, respectively. Patients with relapse who received autologous stem cell transplantation (ASCT) had a five year overall survival of 92%, compared to 64% among those who did not undergo this procedure (pes-ES
dc.descriptionBackground: Hodgkin lymphoma has a high rate of curability, even in advanced stages. Aim: To assess the results of Hodgkin lymphoma treatment using the ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy regimen. Material and methods: Analysis of a database held by the Chilean Ministry of Health, including all patients treated at accredited cancer treatment centers. Results: Data for915 patients, median age 35 years (range 15-86 years) and followed for a median of 97 months (range 1-347 months) were analyzed. Forty-one percent had localized disease. Overall survival at five years for localized and advanced stages was 92% and 74%, respectively. The figures for progression free survival were 87% and 64%, respectively. Patients with relapse who received autologous stem cell transplantation (ASCT) had a five year overall survival of 92%, compared to 64% among those who did not undergo this procedure (pen-US
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/7205/4993
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/38066
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/38067
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/38068
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/38332
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/38343
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/39676
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/39677
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/7205/40249
dc.sourceRevista Médica de Chile; Vol. 147, núm. 4 (2019): ABRIL 2019es-ES
dc.source0034-9887
dc.subjectDrug Therapy; Hodgkin Disease; Stem Cell Transplantation; Survivales-ES
dc.subjectDrug Therapy; Hodgkin Disease; Stem Cell Transplantation; Survivalen-US
dc.titleEvaluación del tratamiento de Linfoma de Hodgkin con esquema ABVD en Chilees-ES
dc.titleTREATMENT OF HODGKIN LYMPHOMA. ANALYSIS OF 915 PATIENTSen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record